Benralizumab for severe DRESS in two COVID-19 patients

J Allergy Clin Immunol Pract. 2021 Jan;9(1):481-483.e2. doi: 10.1016/j.jaip.2020.09.039. Epub 2020 Oct 8.

¹ Faculty of Medicine, University of Zurich, Zurich, Switzerland; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
² Faculty of Medicine, University of Zurich, Zurich, Switzerland; Institute for Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.
³ Department of Dermatology, University of California, Davis, Sacramento, Calif.
⁴ Faculty of Medicine, University of Zurich, Zurich, Switzerland; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; Department of Dermatology, Hochgebirgsklinik Davos, Davos, Switzerland. Electronic address: [email protected].

No abstract available

Publication types